Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013–2014-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013–2014

Published:2017-10-10 Issue:12 Volume:216 Page:1569-1578
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Silverman Rachel A¹²,Beck Ingrid A³,Kiptinness Catherine²,Levine Molly³,Milne Ross³,McGrath Christine J²,Bii Steve³,Richardson Barbra A²⁴,John-Stewart Grace¹²⁵⁶,Chohan Bhavna²,Sakr Samah R⁷,Kiarie James N⁸,Frenkel Lisa M²³⁵⁶⁹,Chung Michael H¹²⁵

Affiliation:

1. Department of Epidemiology, University of Washington, Seattle

2. Department of Global Health, University of Washington, Seattle

3. Seattle Children’s Research Institute, Washington

4. Department of Biostatistics, University of Washington, Seattle

5. Department of Medicine, University of Washington, Seattle

6. Department of Pediatrics, University of Washington, Seattle

7. Coptic Hospital, Nairobi

8. Department of Obstetrics and Gynaecology, University of Nairobi, Kenya

9. Department of Laboratory Medicine, University of Washington, Seattle

Funder

National Institutes of Health

University of Washington Center for AIDS Research

President’s Emergency Plan for AIDS Relief

Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/216/12/1569/24264058/jix544.pdf

Reference50 articles.

1. Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa;Mutevedzi;Trop Med Int Health,2014

2. Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya;Chung;J Acquir Immune Defic Syndr,2014

3. Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects;Kuritzkes;J Infect Dis,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation;Viruses;2024-08-30

2. Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine);Open Forum Infectious Diseases;2024-06-28

3. Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study;JMIR Public Health and Surveillance;2023-11-17

4. Pretreatment HIV Drug Resistance and the Molecular Transmission Network among HIV-positive 1 Individuals in China in 2022: a Multicenter Observational Study (Preprint);2023-07-17

5. Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens;Viruses;2023-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3